SANGEETHA MCCOLLUM: Open Payments
NPI 1407001795 · SMYRNA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,361 in 127 payments from 30 companies in 2025. Trend: 2023 $2,437 · 2024 $2,726 · 2025 $2,361
Food & beverage: $2,361
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $211 |
| Otsuka America Pharmaceutical, Inc. | 11 | $200 |
| GlaxoSmithKline, LLC. | 10 | $191 |
| AstraZeneca Pharmaceuticals LP | 8 | $187 |
| Lilly USA, LLC | 12 | $185 |
| PFIZER INC. | 9 | $181 |
| Amgen Inc. | 10 | $159 |
| ABBVIE INC. | 7 | $133 |
| Axsome Therapeutics, Inc. | 6 | $112 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $107 |
Products named: REXULTI, TRELEGY ELLIPTA, NURTEC ODT, Ozempic, AIRSUPRA, Kerendia, Veozah, MOUNJARO.
Industry payments across TN — which companies pay providers there.
